Skip to main content

AUNA · Auna S.A.

Track AUNA — free
$4.68 +0.09 (+1.96%) At close · Nov 6
Market Cap
$339.92M
Shares
74.06M
Volume · Nov 6 153.84K Avg daily vol (3M) 173.7K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.68 Open$4.52 Day$4.52–4.70 52W close$4.15–5.98 Avg vol 30d181K Short int435K · 0.6% of shares · 3.1d Short vol52% Last earningsNov 18, 2026 DataMar 2024–Nov 2026

Up next

Nov 17, 2026 Announced · in 1 wks
Nov 18, 2026 Scheduled · in 2 wks

Latest documents

2026
Oct 28
Current report 6-K
Current report

On October 27 2026, Auna transferred its Mexican hospital business to Grupo Salud Auna México Hospitales, S.A. de C.V.; insurance remained with Grupo Salud Auna México, S.A. de C.V., and both businesses remained under Auna’s ultimate ownership.

Oct 22
Current report 6-K
Current report

Auna expects full-year 2026 revenue growth in line with prior guidance, but consolidated Adjusted EBITDA broadly stable year over year due to temporary cost pressure from a Colombian payor contract and advanced-stage cancer cases.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-15.5%
Trailing year
Short interest
0.6%
Latest settlement · 3.1 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Moderate
Market backdrop VIX 28.2 · fear Equity put/call 0.89
Technical
price trend
Strong Sell
50 / 200-day cross Death cross
Price vs 200-day avg −8%
below
Price vs 50-day avg −8%
below
RSI (14) 40
neutral
MACD trend Negative
52-week position 29%
mid-range
Momentum
relative strength
Very Weak
1-month return −9%
trailing
6-month return −4%
trailing
YTD return −5%
this year
Relative strength −3%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) Death cross
50d $5 › 200d $5 — 200d above 50d
Institutional flow Distributing
13 of 53 funds reported for Sep 30 · net -76.3K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.59% of shares out · ▼ -25.3% MoM · 3.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
53 holders — near 2-yr high, broad support
Squeeze score 35
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Moderate
Volatility 44%
annualized · 1-yr
Max drawdown −31%
past year
ATR 3.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 19, 2026
Revenue · full year 2026 12%
Adjusted EBITDA growth · full year 2026 Non-GAAP 10% – 14%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
Death cross Bearish
Price vs 200-day avg
−8% Bearish
Price vs 50-day avg
−8% Bearish
RSI (14)
40 Neutral
MACD trend
Negative Bearish
52-week position
29% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) Death cross
50d $5 › 200d $5 — 200d above 50d
Institutional flow Distributing
13 of 53 funds reported for Sep 30 · net -76.3K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.59% of shares out · ▼ -25.3% MoM · 3.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
53 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $4 Now $5 · 29% Range high $6
vs 200-day avg -8% vs 50-day avg -8% 50-day below 200-day death cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AUNA
Auna S.A.
this stock
$339.92M -4.9% — — 0.6%
HCA
HCA Healthcare, Inc.
$106.01B +6.0% +7.1% 16.8 2.3%
FSNUY
Fresenius SE & Co. KGaA
$32.49B +0.6% — — 0.0%
THC
Tenet Healthcare Corp
$22.55B +42.6% +0.9% 8.2 2.3%
EHC
Encompass Health Corp
$13.86B +29.6% +10.5% 22.1 3.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
50
% held
8.0%
Reported
13 of 53
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
3
View
Short & Settlement
Short Interest Falling
Shares short
434.9K
Days to cover
3.1d
Change
-147.5K sh
View
Short Volume
Short vol %
52%
As of
Nov 6, 2026
Short Total
View
Fails to Deliver
FTD shares
4.3K
Value
$22.3K
As of
Sep 17, 2026
View
Off-Exchange
Off-exchange %
41.2%
Week of
Sep 28, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 28, 2026
This year
12

On October 27 2026, Auna transferred its Mexican hospital business to Grupo Salud Auna México Hospitales, S.A. de C.V.; insurance remained with Grupo Salud Auna México, S.A. de C.V., and both businesses remained under Auna’s ultimate ownership.

View
Proposed Sales
Value
$73.8K
Shares
17.6K
Filed
May 28, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 18, 2026
Last webcast
Aug 19, 2026
View
Investor Relations
Latest news
Auna Announces Preliminary Update…
Published
Oct 22, 2026
Upcoming events
3
View

Performance

5D 20D 120D MTD YTD
AUNA +3.8% -8.6% -3.7% +3.8% -4.9%
SPY -2.7% -5.6% -0.5% -2.7% +7.8%
vs SPY +6.5% -3.0% -3.3% +6.5% -12.7%
Key facts CIK 1799207 CUSIP L0415A103 13F (30d) 13 filings 12 filers Visit website Investor relations